Get Analysts' Upgrades and Downgrades Daily

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Anthem, Inc. (NYSE:ANTM) Stake Maintained by Meyer Handelman Co.

Meyer Handelman Co. maintained its position in Anthem, Inc. (NYSE:ANTM) during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 2,100 shares of the company’s stock at the end of the second quarter. Meyer Handelman Co.’s holdings in Anthem were worth $395,000 at the end of the most recent quarter.

Get Analysts' Upgrades and Downgrades Daily

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Several other hedge funds and other institutional investors also recently added to or reduced their stakes in the stock. Hefty Wealth Partners increased its position in Anthem by 3,035.7% in the first quarter. Hefty Wealth Partners now owns 6,585 shares of the company’s stock valued at $1,089,000 after buying an additional 6,375 shares during the period. Acropolis Investment Management LLC increased its position in Anthem by 7.9% in the first quarter. Acropolis Investment Management LLC now owns 9,240 shares of the company’s stock valued at $1,528,000 after buying an additional 677 shares during the period. Fulton Bank N.A. increased its position in Anthem by 44.1% in the first quarter. Fulton Bank N.A. now owns 2,537 shares of the company’s stock valued at $420,000 after buying an additional 776 shares during the period. Swarthmore Group Inc. bought a new position in Anthem during the first quarter valued at approximately $18,423,000. Finally, Chevy Chase Trust Holdings Inc. increased its position in Anthem by 4.0% in the first quarter. Chevy Chase Trust Holdings Inc. now owns 230,710 shares of the company’s stock valued at $38,155,000 after buying an additional 8,957 shares during the period. 88.66% of the stock is owned by institutional investors and hedge funds.

Anthem, Inc. (NYSE:ANTM) traded down 0.02% during mid-day trading on Friday, hitting $190.65. 1,227,876 shares of the stock traded hands. The firm has a market cap of $50.52 billion, a price-to-earnings ratio of 18.47 and a beta of 0.73. Anthem, Inc. has a 1-year low of $114.85 and a 1-year high of $194.94. The stock has a 50-day moving average of $189.74 and a 200 day moving average of $171.52.

Anthem (NYSE:ANTM) last posted its quarterly earnings data on Wednesday, April 26th. The company reported $4.68 earnings per share for the quarter, topping the consensus estimate of $3.85 by $0.83. The business had revenue of $22.32 billion during the quarter, compared to the consensus estimate of $21.23 billion. Anthem had a net margin of 3.19% and a return on equity of 13.13%. The company’s quarterly revenue was up 9.9% compared to the same quarter last year. During the same quarter in the prior year, the company posted $3.46 earnings per share. On average, equities analysts expect that Anthem, Inc. will post $11.78 EPS for the current year.

The business also recently disclosed a quarterly dividend, which was paid on Friday, June 23rd. Investors of record on Friday, June 9th were issued a $0.65 dividend. This represents a $2.60 annualized dividend and a yield of 1.36%. The ex-dividend date of this dividend was Wednesday, June 7th. Anthem’s payout ratio is currently 25.22%.

TRADEMARK VIOLATION WARNING: This report was first published by [[site]] and is owned by of [[site]]. If you are accessing this report on another site, it was illegally stolen and republished in violation of international copyright laws. The original version of this report can be read at [[permalink]].

Several research analysts have commented on the stock. Bank of America Corporation increased their price objective on shares of Anthem from $224.00 to $228.00 and gave the company a “buy” rating in a report on Friday, July 14th. Jefferies Group LLC reissued a “hold” rating and set a $204.00 price objective on shares of Anthem in a report on Friday, July 14th. Deutsche Bank AG increased their price objective on shares of Anthem from $173.00 to $185.00 and gave the company a “hold” rating in a report on Thursday, July 13th. Credit Suisse Group assumed coverage on shares of Anthem in a report on Wednesday, July 12th. They set a “neutral” rating and a $195.00 price objective for the company. Finally, BidaskClub downgraded shares of Anthem from a “strong-buy” rating to a “buy” rating in a report on Wednesday. Twelve investment analysts have rated the stock with a hold rating and ten have assigned a buy rating to the stock. Anthem presently has a consensus rating of “Hold” and an average target price of $174.26.

In related news, Director Julie A. Hill sold 555 shares of the company’s stock in a transaction dated Wednesday, May 24th. The shares were sold at an average price of $180.56, for a total value of $100,210.80. Following the completion of the sale, the director now owns 37,448 shares of the company’s stock, valued at $6,761,610.88. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director Ramiro G. Peru sold 2,681 shares of the company’s stock in a transaction dated Tuesday, May 30th. The stock was sold at an average price of $181.58, for a total transaction of $486,815.98. Following the completion of the sale, the director now directly owns 13,571 shares of the company’s stock, valued at approximately $2,464,222.18. The disclosure for this sale can be found here. Insiders sold 4,103 shares of company stock valued at $749,555 in the last ninety days. Corporate insiders own 0.36% of the company’s stock.

Anthem Company Profile

Anthem, Inc is a health benefits company. The Company operates through three segments: Commercial and Specialty Business, Government Business and Other. It offers a spectrum of network-based managed care plans to large and small employer, individual, Medicaid and Medicare markets. Its managed care plans include preferred provider organizations; health maintenance organizations; point-of-service plans; indemnity plans and other hybrid plans, including consumer-driven health plans; and hospital only and limited benefit products.